VERTEX PHARMACEUTICALS INC / MA (VRTX)

SEC filing

VERTEX PHARMACEUTICALS INC / MA

VRTX · CIK 875320

4 · Sep 1, 2026 · SVP & Chief Accounting Officer Ambrose Kristen was granted 5,000 shares

SVP & Chief Accounting Officer Ambrose Kristen was granted 5,000 shares

Could not load the primary document from EDGAR (SEC rate limit, timeout, or temporary upstream error). Refresh in a minute, or use View on SEC.gov.